105
Participants
Start Date
August 13, 2024
Primary Completion Date
February 28, 2025
Study Completion Date
August 30, 2025
rosuvastatin
"Stude include three groupsof people GroupA: recieve rosuvastatin 40mg Group B :recive rosuvastatin 20mg Group C: recive placebo 2- Follow up will be done using NIHSS at the onset and modified Rankin scale at the onset and after 1 month and 3 months of the onset.~3- Carotid duplex will be done at the onset and after 1 month and 3 months of the onset."
Assiut University
OTHER